Ritsuko Komaki

Ritsuko Komaki

UNVERIFIED PROFILE

Are you Ritsuko Komaki?   Register this Author

Register author
Ritsuko Komaki

Ritsuko Komaki

Publications by authors named "Ritsuko Komaki"

Are you Ritsuko Komaki?   Register this Author

100Publications

3541Reads

25Profile Views

Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.

Clin Lung Cancer 2019 03 29;20(2):117-123. Epub 2018 Nov 29.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.11.013DOI Listing
March 2019

James Daniel Cox, MD, FASTRO, FACR.

Int J Radiat Oncol Biol Phys 2019 03;103(4):784-785

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.09.025DOI Listing
March 2019

My Path from Hiroshima to Houston.

Authors:
Ritsuko Komaki

Pract Radiat Oncol 2019 01 14;9(1):1-2. Epub 2017 Oct 14.

Radiation Oncology, Gloria Lupton Tennison Distinguished Endowed Professorship in Lung Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2017.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899690PMC
January 2019

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis.

Radiat Oncol 2018 Dec 29;13(1):258. Epub 2018 Dec 29.

Department of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-1205-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310962PMC
December 2018

Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.

Clin Lung Cancer 2018 11 22;19(6):e885-e891. Epub 2018 Aug 22.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183020
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.08.012DOI Listing
November 2018

Anticancer therapy and lung injury: molecular mechanisms.

Expert Rev Anticancer Ther 2018 10 23;18(10):1041-1057. Epub 2018 Jul 23.

a Department of Radiation Oncology , Baylor College of Medicine , Houston , Texas , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1500180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290681PMC
October 2018

Hematologic variables associated with brain failure in patients with small-cell lung cancer.

Radiother Oncol 2018 09 12;128(3):505-512. Epub 2018 Jun 12.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.05.026DOI Listing
September 2018

Reirradiation of thoracic cancers with intensity modulated proton therapy.

Pract Radiat Oncol 2018 Jan - Feb;8(1):58-65. Epub 2017 Jul 8.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2017.07.002DOI Listing
August 2018

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

JAMA Oncol 2018 08 9;4(8):e174504. Epub 2018 Aug 9.

Division of Radiation of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.4504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885163PMC
August 2018

Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.

Int J Radiat Oncol Biol Phys 2018 07 12;101(4):919-926. Epub 2018 Apr 12.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.04.012DOI Listing
July 2018

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 06 2;36(18):1813-1822. Epub 2018 Jan 2.

Zhongxing Liao, J. Jack Lee, Ritsuko Komaki, Daniel R. Gomez, Michael S. O'Reilly, Frank V. Fossella, George R. Blumenschein Jr, John V. Heymach, Ara A. Vaporciyan, Stephen G. Swisher, Pamela K. Allen, Stephen M. Hahn, James D. Cox, Charles S. Lu, and Radhe Mohan, The University of Texas MD Anderson Cancer Center, Houston, TX; and Noah Chan Choi and Thomas F. DeLaney, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.0720
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.0720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008104PMC
June 2018

Is prophylactic cranial irradiation indicated for patients with extensive-stage small cell lung cancer with a complete response to first-line treatment?

Radiother Oncol 2018 06 7;127(3):339-343. Epub 2018 May 7.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.03.034DOI Listing
June 2018

Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.

J Thorac Oncol 2018 05 15;13(5):660-675. Epub 2018 Feb 15.

Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.01.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124306PMC
May 2018

Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.

Radiother Oncol 2018 Mar 2;126(3):499-505. Epub 2018 Feb 2.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.12.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856620PMC
March 2018

Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.

Pract Radiat Oncol 2017 May - Jun;7(3):e195-e203. Epub 2016 Sep 13.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18798500163018
Publisher Site
http://dx.doi.org/10.1016/j.prro.2016.09.005DOI Listing
February 2018

Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.

Int J Radiat Oncol Biol Phys 2018 02 12;100(2):452-461. Epub 2017 Oct 12.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.10.003DOI Listing
February 2018

RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.

Clin Cancer Res 2018 01 13;24(2):341-350. Epub 2017 Oct 13.

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1455DOI Listing
January 2018

F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.

J Nucl Med 2017 11 18;58(11):1756-1763. Epub 2017 May 18.

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.192591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666643PMC
November 2017

Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.

J Thorac Oncol 2017 11 10;12(11):1696-1703. Epub 2017 Aug 10.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.07.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729749PMC
November 2017

Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer.

Int J Radiat Oncol Biol Phys 2017 10 6;99(2):407-416. Epub 2017 Jun 6.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.05.050DOI Listing
October 2017

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.

Radiother Oncol 2017 10 13;125(1):48-54. Epub 2017 Sep 13.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.07.034DOI Listing
October 2017

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

Int J Radiat Oncol Biol Phys 2017 09 1;99(1):128-135. Epub 2017 Jun 1.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.05.037DOI Listing
September 2017

Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature.

Front Oncol 2017 29;7:228. Epub 2017 Sep 29.

Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626817PMC
September 2017

The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.

Radiother Oncol 2017 08 4;124(2):318-324. Epub 2017 Jul 4.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.06.019DOI Listing
August 2017

Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old.

Int J Radiat Oncol Biol Phys 2017 07 1;98(4):811-819. Epub 2017 Mar 1.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.02.097DOI Listing
July 2017

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

J Thorac Oncol 2017 06 27;12(6):1001-1010. Epub 2017 Mar 27.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.03.017DOI Listing
June 2017

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus.

Adv Radiat Oncol 2017 Jul-Sep;2(3):325-332. Epub 2017 Mar 27.

Department of Experimental Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2017.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605280PMC
March 2017

Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?

Radiother Oncol 2017 02 7;122(2):307-312. Epub 2017 Jan 7.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.11.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319879PMC
February 2017

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

J Clin Oncol 2017 Jan 31;35(1):56-62. Epub 2016 Oct 31.

Stephen G. Chun and Ritsuko U. Komaki, University of Texas MD Anderson Cancer Center, Houston; Hak Choy, Robert D. Timmerman, and Puneeth Iyengar, University of Texas Southwestern Medical Center, Dallas; Vivek S. Kavadi, Texas Oncology-Sugar Land, Sugar Land, TX; Chen Hu and Rebecca Paulus, NRG Oncology Statistics and Data Management Center; James M. Galvin, Imaging and Radiation Oncology Core, Philadelphia; Raymond B. Wynn, UPMC Cancer Center, Pittsburg, PA; Chen Hu, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Steven E. Schild, Mayo Clinic, Scottsdale, AZ; Jeffrey A. Bogart, State University of New York Upstate Medical University, Syracuse, NY; Michael C. Dobelbower, University of Alabama at Birmingham, Birmingham, AL; Walter Bosch, Clifford G. Robinson, and Jeffrey D. Bradley, Washington University in Saint Louis, St Louis, MO; Samir Narayan, Michigan Cancer Research Consortium Community Clinical Oncology Program, Ann Arbor, MI; Adam Raben, Christiana Care Health Services Community Clinical Oncology Program, Newark, DE; Mark E. Augspurger, Florida Radiation Oncology Group; Baptist Health, Jacksonville, FL; and Robert M. MacRae, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455690PMC
January 2017

Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.

Clin Cancer Res 2016 Dec 28;22(23):5876-5886. Epub 2016 Jun 28.

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135582PMC
December 2016

Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.

Radiother Oncol 2016 10 22;121(1):70-74. Epub 2016 Aug 22.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140163124
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2016.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546146PMC
October 2016

Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer.

Acta Oncol 2016 Aug 8;55(8):1022-8. Epub 2016 Apr 8.

a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2016.1154602DOI Listing
August 2016

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

J Natl Compr Canc Netw 2016 07;14(7):825-36

From The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; City of Hope Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0087DOI Listing
July 2016

Motion-robust intensity-modulated proton therapy for distal esophageal cancer.

Med Phys 2016 Mar;43(3):1111-8

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4940789DOI Listing
March 2016

PDL1 Regulation by p53 via miR-34.

J Natl Cancer Inst 2016 Jan 17;108(1). Epub 2015 Nov 17.

Departments of Experimental Radiation Oncology (MAC, DV, XW, YY), Experimental Therapeutics (CI, GAC), and Radiation Oncology (RK, DRG, SK, JWW), The University of Texas MD Anderson Cancer Center, Houston, TX; Mirna Therapeutics, Inc., Austin, TX (HJP, KK, DM, AGB); Ohio State University, Columbus, OH (LA, DPC, KS); Texas Veterinary Pathology Associates (Houston), Houston, TX (DKG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862407PMC
January 2016

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Neuro Oncol 2015 Jul 10;17(7):992-8. Epub 2015 Mar 10.

Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York (A.B.L. current); Memorial Sloan Kettering Cancer Center, New York, New York (A.B.L. during accrual, L.M.D.); NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania (S.L.P., S.G., M.W); The University of Texas MD Anderson Cancer Center, Houston, Texas (M.R.G., K.D.A. during accrual; R.K.); Neuro-Oncology Branch, National Cancer Institute/National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (M.R.G. current); University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada (K.D.A. current); Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania (J.H.B., S.M.C.); Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy Pittsburgh, Pennsylvania (J.H.B.); NCI Community Oncology Research Program - Kansas City, Prairie Village, Kansas (R.G.); Arizona Oncology Services Foundation, Tucson, Arizona (E.Y.); Penn State University and The Milton S. Hershey Medical Center, Hershey, Pennsylvania (H.W.); University of Maryland Medical Systems, Baltimore, Maryland (M.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762006PMC
July 2015

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.

BMC Cancer 2015 9;15:1095. Epub 2015 Mar 9.

Department of Radiation Oncology, Cancer Center, Sun Yat-Sun University, Guangzhou, China,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1095-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359440PMC
July 2015

Non-Small Cell Lung Cancer, Version 6.2015.

J Natl Compr Canc Netw 2015 May;13(5):515-24

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0071DOI Listing
May 2015

Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas.

J Thorac Oncol 2015 Mar;10(3):518-26

*Department of Radiation Oncology, and †Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335306PMC
March 2015

Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.

Radiother Oncol 2014 Dec 25;113(3):379-84. Epub 2014 Nov 25.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2014.11.006DOI Listing
December 2014